Pendulum Therapeutics

Pendulum Therapeutics is a privately held biotechnology and consumer health company founded in 2012 and headquartered in San Francisco, California. Co-founded by Dr. Colleen Cutcliffe, Dr. John Eid, and Jim Bullard, the company focuses on translating microbiome research into probiotic products for consumers. Its mission is to develop microbiome-based solutions that make scientific advances more accessible for everyday health and wellness.

The company’s portfolio includes Metabolic Daily, Akkermansia, and other specialized probiotic formulations. Pendulum emphasizes research-led product development, proprietary microbial strains, and collaboration with scientists and healthcare professionals. Its educational content helps consumers understand the relationship between the gut microbiome, digestion, and metabolic health. The company also highlights clinical research collaborations as part of its approach to developing and evaluating products.

Pendulum operates at the intersection of biotechnology, consumer health, and functional nutrition. Its commercial activities include direct-to-consumer e-commerce, brand marketing, customer education, healthcare-provider engagement, and strategic partnerships. These activities create potential opportunities for growth marketing, customer acquisition, lifecycle email campaigns, and business development collaborations. Any health-related product claims should be assessed against the supporting evidence and applicable regulatory requirements.